Skip to content

Democratizing Access to Cleaner Residential Air

Democratizing Access to Cleaner Residential Air

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07629518
Acronym
DACRA
Enrollment
66
Registered
2026-06-05
Start date
2026-09-01
Completion date
2029-05-01
Last updated
2026-06-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular (CV) Risk

Keywords

air pollution, air purifiers, HEPA filtration, cardiovascular risk, biomarkers

Brief summary

The purpose of this research study is to determine whether the use of in-home air filtration to reduce exposure to air pollution benefits health.

Detailed description

Conduct a randomized crossover pilot trial with 66 participants to calculate preliminary effect size estimates to inform a larger crossover efficacy trial: We will: 1) enroll 66 individuals living in low and high traffic areas in Hartford (N=44) and a highly polluted urban areas in Boston Chinatown (N=22); and 2) install full filtration DIYAPs and sham DIYAPs for 30 days each in a randomized crossover trial design with a 14-day wash-out in between; and 3) measure seated and ambulatory BP, administer the SF-12v2, the Trail Making Test Part B, collect blood, and measure both indoor and outdoor PM (in size bins).

Interventions

OTHERPortable air purifiers with HEPA filtration

Portable air purifiers filter air and reduce exposure to air pollutants, in this case, airborne particulate matter

OTHERPortable air purifiers without filtration (sham)

Air purifiers with filters removed (sham)

Sponsors

Douglas Brugge
Lead SponsorOTHER
National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Intervention model description

Double blind, randomized crossover

Eligibility

Sex/Gender
ALL
Age
40 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

Age 40 years or older Speaks English, Vietnamese, and/or Chinese Cognitive capacity to respond to questionnaires Lives fulltime at the current address, adjacent (\< 200 meters) to roadways with large traffic volumes Must have one or more risk factors (hypertension or elevated blood pressure, pre-diabetes or diabetes or elevated blood sugar levels, elevated cholesterol levels, body mass index 25 or greater)

Exclusion criteria

Pregnant Works between the hours of 10 PM and 6 AM Sources of smoke in the living space (such as candles, incense, marijuana, wood stove, fireplace) almost every day/every day. Every day exposure to motor vehicle exhaust (from cars, trucks, buses, trains), including heavy street or highway traffic. Currently smoking or vaping Others smoking or vaping indoors, in the living space. Within the past 5 years, a diagnosis of heart attack, heart disease, stroke, blood clots or pulmonary embolism, cancer requiring surgery and/or chemo/radiation therapy

Design outcomes

Primary

MeasureTime frameDescription
Blood pressureDay 0, 30, 45, and 75Periferal blood pressure, seated

Secondary

MeasureTime frameDescription
IL-1betaDay 0, 30, 45, and 75Blood inflammatory biomarker

Contacts

CONTACTDoug Brugge, PhD
brugge@uchc.edu18606748814
PRINCIPAL_INVESTIGATORDoug M Brugge

UConn Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 6, 2026